Menu
GeneBe

PCGF2

polycomb group ring finger 2, the group of Ring finger proteins|Polycomb group ring fingers

Basic information

Region (hg38): 17:38733897-38749817

Previous symbols: [ "ZNF144", "RNF110" ]

Links

ENSG00000277258NCBI:7703OMIM:600346HGNC:12929Uniprot:P35227AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • turnpenny-fry syndrome (Limited), mode of inheritance: AD
  • turnpenny-fry syndrome (Strong), mode of inheritance: AD
  • turnpenny-fry syndrome (Strong), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Turnpenny-Fry syndromeADCardiovascularThe condition can involve congenital cardiac anomalies, and awareness may allow early managementCardiovascular; Craniofacial; Musculoskeletal; Neurologic25533962; 30343942

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PCGF2 gene.

  • not provided (150 variants)
  • Inborn genetic diseases (18 variants)
  • Turnpenny-fry syndrome (6 variants)
  • not specified (3 variants)
  • Intellectual disability;Abnormality of the outer ear (1 variants)
  • Global developmental delay (1 variants)
  • PCGF2-related condition (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PCGF2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
31
clinvar
6
clinvar
37
missense
3
clinvar
60
clinvar
5
clinvar
10
clinvar
78
nonsense
0
start loss
0
frameshift
2
clinvar
2
inframe indel
3
clinvar
3
splice donor/acceptor (+/-2bp)
0
splice region
1
6
3
10
non coding
1
clinvar
19
clinvar
6
clinvar
26
Total 0 3 66 55 22

Variants in PCGF2

This is a list of pathogenic ClinVar variants found in the PCGF2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
17-38734160-C-T Benign (Oct 01, 2022)2647704
17-38735214-T-A PCGF2-related disorder Likely benign (Dec 23, 2019)3048124
17-38735229-T-G not specified Uncertain significance (May 04, 2022)1684991
17-38735231-AG-A Wolfram syndrome 2 • Turnpenny-fry syndrome Uncertain significance (Mar 25, 2024)3064520
17-38735233-G-C Inborn genetic diseases Uncertain significance (Jul 07, 2023)2159950
17-38735233-G-T Inborn genetic diseases Conflicting classifications of pathogenicity (Nov 17, 2022)1560211
17-38735234-G-C Uncertain significance (Oct 13, 2023)1955106
17-38735240-C-T Inborn genetic diseases Likely benign (Aug 05, 2023)2192218
17-38735241-G-A Likely benign (Nov 26, 2023)1633188
17-38735242-G-A Uncertain significance (Oct 25, 2022)1902857
17-38735247-G-A Likely benign (Jan 22, 2024)1436087
17-38735250-G-C Uncertain significance (Oct 30, 2023)2024151
17-38735253-G-A Likely benign (Oct 06, 2023)1589301
17-38735257-G-T not specified Uncertain significance (Feb 26, 2024)3069065
17-38735267-G-A Inborn genetic diseases Uncertain significance (Apr 25, 2022)2285890
17-38735267-G-C Uncertain significance (Nov 27, 2023)2034727
17-38735267-GC-G Uncertain significance (Jan 24, 2023)3004541
17-38735287-G-A Uncertain significance (Jan 27, 2022)2090427
17-38735309-T-A Uncertain significance (Jun 05, 2022)1924870
17-38735312-C-T Inborn genetic diseases Uncertain significance (Jul 12, 2022)2301194
17-38735313-C-A Likely benign (Oct 03, 2023)1933140
17-38735314-C-T Uncertain significance (Aug 16, 2022)1478692
17-38735315-C-T Uncertain significance (Jan 12, 2024)2909809
17-38735316-G-A Likely benign (Feb 11, 2022)1965524
17-38735320-G-A PCGF2-related disorder Benign (Jan 18, 2024)1598615

GnomAD

Source: gnomAD

dbNSFP

Source: dbNSFP

Function
FUNCTION: Transcriptional repressor. Binds specifically to the DNA sequence 5'-GACTNGACT-3'. Has tumor suppressor activity. May play a role in control of cell proliferation and/or neural cell development. Regulates proliferation of early T progenitor cells by maintaining expression of HES1. Also plays a role in antero- posterior specification of the axial skeleton and negative regulation of the self-renewal activity of hematopoietic stem cells (By similarity). Component of a Polycomb group (PcG) multiprotein PRC1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. PcG PRC1 complex acts via chromatin remodeling and modification of histones; it mediates monoubiquitination of histone H2A 'Lys-119', rendering chromatin heritably changed in its expressibility (PubMed:26151332). Within the PRC1-like complex, regulates RNF2 ubiquitin ligase activity (PubMed:26151332). {ECO:0000250|UniProtKB:P23798, ECO:0000269|PubMed:26151332}.;
Pathway
Signaling pathways regulating pluripotency of stem cells - Homo sapiens (human);Gene expression (Transcription);Transcriptional Regulation by E2F6;Generic Transcription Pathway;SUMOylation of DNA damage response and repair proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;Post-translational protein modification;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;RNA Polymerase II Transcription;SUMOylation (Consensus)

Recessive Scores

pRec
0.108

Intolerance Scores

loftool
0.332
rvis_EVS
-0.43
rvis_percentile_EVS
25.15

Haploinsufficiency Scores

pHI
0.287
hipred
Y
hipred_score
0.580
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
gene_indispensability_pred
E
gene_indispensability_score
0.685

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Pcgf2
Phenotype
mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; embryo phenotype; immune system phenotype; skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; digestive/alimentary phenotype; vision/eye phenotype; craniofacial phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype;

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;in utero embryonic development;chromatin silencing;anterior/posterior pattern specification;histone acetylation;histone H2A-K119 monoubiquitination;embryonic skeletal system morphogenesis;cellular response to hydrogen peroxide;negative regulation of G0 to G1 transition;negative regulation of apoptotic signaling pathway
Cellular component
nuclear chromatin;sex chromatin;nucleus;nucleoplasm;nuclear body;PcG protein complex;PRC1 complex
Molecular function
DNA binding;DNA-binding transcription factor activity;protein binding;metal ion binding;promoter-specific chromatin binding